Whole-body tumor imaging using PET and 2-18F-fluoro-L-tyrosine: preliminary evaluation and comparison with 18F-FDG (original) (raw)
First Clinical Results of (D)-18F-Fluoromethyltyrosine (BAY 86-9596) PET/CT in Patients with Non-Small Cell Lung Cancer and Head and Neck Squamous Cell Carcinoma
Roger Schibli
Journal of Nuclear Medicine, 2014
View PDFchevron_right
PET with L-[1-carbon-11]-tyrosine to visualize tumors and measure protein synthesis rates
J. Pruim
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1997
View PDFchevron_right
Unparalleled contribution of 18F-FDG PET to medicine over 3 decades
Abass Alavi
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2008
View PDFchevron_right
Evaluation of O-[18F]fluoromethyl-d-tyrosine as a radiotracer for tumor imaging with positron emission tomography
Hideo Tsukada
Nuclear Medicine and Biology, 2009
View PDFchevron_right
Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes
Hongming Zhuang
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2001
View PDFchevron_right
F-18 FDG-PET and PET/CT Imaging of Cancer Patients
Nghi Nguyen
Journal of Radiology Nursing, 2008
View PDFchevron_right
The role of 18F-FDG PET in oncology: clinical and resource implications
AVIRAL SINGH
Nuclear medicine review. Central & Eastern Europe, 2006
View PDFchevron_right
Two Decades of Brain Tumour Imaging with O-(2-[18F]fluoroethyl)-L-tyrosine PET: The Forschungszentrum Jülich Experience
Kim Dillen
Cancers
View PDFchevron_right
Effects of Intratumoral Inflammatory Process on 18F-FDG Uptake: Pathologic and Comparative Study with 18F-Fluoro-α-Methyltyrosine PET/CT in Oral Squamous Cell Carcinoma
Yoshito Tsushima
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015
View PDFchevron_right
Can the Efficacy of [18F]FDG-PET/CT in Clinical Oncology Be Enhanced by Screening Biomolecular Profiles?
Vinod Malik
Pharmaceuticals
View PDFchevron_right
18FDG PET in oncology: The best and the worst (Review)
Tarik-Zine Belhocine
International Journal of Oncology, 2006
View PDFchevron_right
Applications of 18(F) FDG PET/CT in oncology
ahmad saad
2015
View PDFchevron_right
Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials
Lalitha Shankar
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2006
View PDFchevron_right
Kostakoglu, L. & Goldsmith, S. J. 18F-FDG PET evaluation of the response to therapy for lymphoma and for breast, lung, and colorectal carcinoma. J. Nucl. Med. 44, 224-239
Lale Kostakoglu
Journal of Nuclear Medicine
View PDFchevron_right
18F-FDG PET Evaluation of the Response to Therapy for Lymphoma and for Breast, Lung, and Colorectal Carcinoma
Lale Kostakoglu
2000
View PDFchevron_right
L-Amino acid load to enhance PET differentiation between tumor and inflammation: anin vitro study on18F-FET uptake
Camilo Garcia
Contrast Media & Molecular Imaging, 2006
View PDFchevron_right
FDG-PET Determination of Metabolically Active Tumor Volume and Comparison with CT
Ken Zasadny
Clinical Positron Imaging, 1998
View PDFchevron_right
L-[1-11C]-Tyrosine PET to Evaluate Response to Hyperthermic Isolated Limb Perfusion for Locally Advanced Soft-Tissue Sarcoma and Skin Cancer
Ineke Molenaar
Journal of Nuclear Medicine, 1999
View PDFchevron_right
Reproducibility of18F-FDG PET uptake measurements in head and neck squamous cell carcinoma on both PET/CT and PET/MR
Lena Specht
British Journal of Radiology, 2015
View PDFchevron_right
Imaging Gastric Cancer with PET and the Radiotracers 18F-FLT and 18F-FDG: A Comparative Analysis
ken buck
View PDFchevron_right
Combined functional and structural evaluation of cancer patients with a hybrid camera-based PET/CT system using (18)F-FDG
Luda Guralnik, Abraham Kuten
Journal of Nuclear Medicine Official Publication Society of Nuclear Medicine, 2002
View PDFchevron_right